100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE Anti-Mouse CD272 Antibody [PK18.6] (AGEL0755)

SKU AGEL0755
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Mouse
Applications FC
€82 - €200

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Mouse CD272 Antibody [PK18.6]

The PE-conjugated Mouse CD272 Monoclonal Antibody (PK18-6) is a cutting-edge tool designed for researchers studying CD272, an important immune-related molecule involved in the regulation of immune responses. This monoclonal antibody, specifically developed for use with mouse samples, offers high reactivity and precision in detecting CD272 protein expression. Validated for applications such as flow cytometry, this antibody provides researchers with a reliable means of identifying and analyzing CD272 in various cell types.CD272, also known as B- and T-lymphocyte attenuator (BTLA), is a key immune checkpoint receptor that plays a crucial role in modulating immune responses.

By inhibiting immune cell activation, CD272 contributes to the regulation of immune tolerance and autoimmunity. Its significance in immune regulation makes it a promising target for research in fields such as immunology and cancer biology. Understanding the function of CD272 is essential for developing novel therapeutic strategies aimed at manipulating immune responses and potentially treating immune-related disorders such as cancer and autoimmune diseases.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose